Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 5 years
- Director since
- 2023
5 years of board service in total across 3 boards, counting each seat separately. Longest: Moderna Inc., 3 years.
Moderna Inc.
Director
Foghorn Therapeutics Inc.
Director
Generate Biomedicines Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| May 21, 2026 | Moderna Inc. | Option exercise | +9,263 | $19.15 | $177,386 |
| May 21, 2026 | Moderna Inc. | Open-market sale | −9,263 | $46.84 | $433,879 |
| Mar 2, 2026 | Generate Biomedicines Inc. | Derivative conversion | +12,723,940 | — | — |
| Mar 2, 2026 | Generate Biomedicines Inc. | Derivative conversion | +12,723,940 | — | — |
| Mar 2, 2026 | Generate Biomedicines Inc. | Derivative conversion | +13,702,224 | — | — |
| Mar 2, 2026 | Generate Biomedicines Inc. | Derivative conversion | +13,702,224 | — | — |
| Mar 2, 2026 | Generate Biomedicines Inc. | Derivative conversion | +987,491 | — | — |
| Mar 2, 2026 | Generate Biomedicines Inc. | Derivative conversion | +987,491 | — | — |
| Mar 2, 2026 | Generate Biomedicines Inc. | Derivative conversion | +2,777,752 | — | — |
| Mar 2, 2026 | Generate Biomedicines Inc. | Derivative conversion | +2,777,752 | — | — |
| Mar 2, 2026 | Generate Biomedicines Inc. | Derivative conversion | +2,777,752 | — | — |
| Mar 2, 2026 | Generate Biomedicines Inc. | Derivative conversion | +2,777,752 | — | — |
| Mar 2, 2026 | Generate Biomedicines Inc. | Open-market purchase | +1,562,500 | $16.00 | $25,000,000 |
| Mar 2, 2026 | Generate Biomedicines Inc. | Open-market purchase | +1,562,500 | $16.00 | $25,000,000 |
| Mar 2, 2026 | Generate Biomedicines Inc. | Open-market purchase | +1,562,500 | $16.00 | $25,000,000 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.